Your browser doesn't support javascript.
loading
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis.
Dalbeni, Andrea; Romano, Simone; Bevilacqua, Michele; Piccoli, Anna; Imbalzano, Egidio; Mantovani, Anna; Benati, Marco; Montagnana, Martina; Donato, Angela; Torin, Gioia; Monaco, Cinzia; Cattazzo, Filippo; Tagetti, Angela; Paon, Veronica; Ieluzzi, Donatella; Iogna Prat, Laura; Roccarina, Davide; Ribichini, Flavio; Capra, Franco; Minuz, Pietro; Fava, Cristiano.
Afiliación
  • Dalbeni A; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Romano S; Division of Liver Unit, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Bevilacqua M; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Piccoli A; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Imbalzano E; Division of Cardiology, Department of Cardiology, University and Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Mantovani A; Division of Internal Medicine, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Benati M; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Montagnana M; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
  • Donato A; Department of Neurosciences, Biomedicine and Movement Sciences, Section of Clinical Biochemistry, University of Verona, Verona, Italy.
  • Torin G; Department of Neurosciences, Biomedicine and Movement Sciences, Section of Clinical Biochemistry, University of Verona, Verona, Italy.
  • Monaco C; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Cattazzo F; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Tagetti A; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Paon V; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Ieluzzi D; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Iogna Prat L; Division of General Medicine and Hypertension, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Roccarina D; Division of Liver Unit, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Ribichini F; Division of Liver Unit, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Capra F; Division of Liver Unit, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Minuz P; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
  • Fava C; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
J Viral Hepat ; 27(11): 1214-1221, 2020 11.
Article en En | MEDLINE | ID: mdl-32593212
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepacivirus / Hepatitis C Crónica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepacivirus / Hepatitis C Crónica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2020 Tipo del documento: Article